By Francesco Guarascio
BRUSSELS, Sept 23 (Reuters) - Brussels is close to wrapping
up preliminary talks with U.S. vaccine maker Novavax
for its potential COVID-19 shot, an EU source involved in the
negotiations said, as the bloc ramps up its push in the global
race to secure supplies.
The move is meant to expand to seven the portfolio of
vaccines the 27-country bloc, with a population of 450 million,
wants to secure. It would bring doses potentially available to
EU countries to more than 2 billion.
(Reporting by Francesco Guarascio; Editing by Josephine Mason
and Jan Harvey)
Glaxosmithkline (GSK)
Astrazeneca (AZN)
